StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
1243
This month
16
This week
2
This year
111
Today
1
Yesterday
2
Publishing Date
2024 - 01 - 17
5
2023 - 12 - 12
5
2023 - 12 - 08
5
2023 - 11 - 01
4
2023 - 10 - 30
4
2023 - 10 - 04
5
2023 - 10 - 03
4
2023 - 10 - 02
4
2023 - 09 - 29
4
2023 - 08 - 28
4
2023 - 08 - 25
7
2023 - 08 - 09
5
2023 - 06 - 12
5
2023 - 06 - 08
7
2023 - 04 - 26
5
2023 - 04 - 25
4
2023 - 04 - 13
6
2023 - 04 - 12
12
2023 - 03 - 16
4
2023 - 02 - 27
4
2023 - 02 - 24
4
2023 - 02 - 22
4
2023 - 02 - 20
5
2023 - 02 - 17
7
2023 - 02 - 16
5
2023 - 02 - 13
6
2023 - 02 - 08
4
2023 - 01 - 18
4
2023 - 01 - 16
4
2022 - 09 - 28
4
2022 - 09 - 19
6
2022 - 09 - 02
4
2022 - 08 - 03
4
2022 - 07 - 25
4
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 22
4
2022 - 06 - 17
6
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 03 - 25
6
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 08
4
2022 - 03 - 04
4
2022 - 03 - 01
4
2021 - 12 - 22
6
2021 - 12 - 20
4
2021 - 10 - 28
4
2021 - 10 - 20
4
2021 - 08 - 31
4
2021 - 08 - 25
4
2021 - 08 - 19
5
2021 - 08 - 05
6
2021 - 06 - 02
4
2021 - 05 - 10
4
2021 - 04 - 13
4
2021 - 03 - 18
5
Sector
Commercial services
12
Communications
8
Consumer durables
5
Consumer non-durables
16
Consumer services
2
Distribution services
4
Electronic technology
19
Finance
6
Health care and social assistance
1
Health services
17
Health technology
1243
Industrial services
1
Information
4
Manufacturing
137
Mining, quarrying, and oil and gas extraction
2
N/a
68
Non-energy minerals
1
Process industries
16
Producer manufacturing
22
Professional, scientific, and technical services
20
Retail trade
3
Technology services
17
Tags
America
67
Antibody
13
Application
12
Approval
21
Biosimilar
39
Breast
13
Cancer
106
Covid
17
Covid-19
12
Device
14
Diabetes
18
Diagnostics
19
Disease
76
Drug
116
Drug delivery
11
Earnings
21
Europe
17
Expansion
12
Expected
35
Eye
21
Fda
28
Financial
24
Financial results
13
Gene therapy
11
Global
229
Growing
47
Growth
263
Health
19
Immunotherapy
12
Kisqali
11
Leukemia
12
Liver
20
Market
600
N/a
1117
Novartis
134
Patent
13
People
20
Pharma
17
Pharmaceuticals
17
Pipeline
12
Positive
19
Potential
13
Reach
34
Report
195
Research
129
Respiratory
15
Results
52
Risk
11
Sales
12
Sclerosis
13
Set
17
Study
17
T-cell
12
Technology
14
Therapeutics
115
Therapy
89
Treatment
137
Trial
25
Vaccine
16
Year
12
Entities
3m company
13
Abbott laboratories
120
Abbvie inc.
239
Abeona therapeutics inc.
7
Adaptimmune therapeutics plc
15
Alcon inc.
15
Alkermes plc
10
Amgen inc.
196
Astellas pharma inc
70
Astrazeneca plc
199
Autolus therapeutics plc
7
Bausch health companies inc.
74
Baxter international inc.
48
Becton, dickinson and company
19
Beigene, ltd.
7
Biogen inc.
54
Biontech se
10
Bluebird bio, inc.
11
Boston scientific corporation
17
Brainstorm cell therapeutics inc.
8
Bristol-myers squibb company
103
Csl ltd
9
Danaher corporation
11
Eli lilly and company
138
Endo international plc
20
General electric company
8
Genmab a/s
21
Gilead sciences, inc.
28
Glaxosmithkline plc
305
Grifols sa
10
Incyte corporation
21
Ionis pharmaceuticals, inc.
9
Jazz pharmaceuticals plc
14
Johnson & johnson
245
Koninklijke philips n.v.
19
Mallinckrodt plc
17
Medtronic plc
36
Morphosys ag
16
Novartis ag
1243
Novo nordisk a/s
28
Orange
8
Orchard therapeutics plc
9
Perrigo company
8
Pfizer, inc.
88
Precision biosciences, inc.
8
Reckitt benckiser group plc
10
Regeneron pharmaceuticals, inc.
13
Regenxbio inc.
12
Sanofi
330
Stryker corporation
12
Takeda pharmaceutical company limited
58
Terumo corp
9
Teva pharmaceutical industries limited
9
Teva pharmaceutical industries ltd
206
Thermo fisher scientific inc
51
Ucb s.a.
8
Uniqure n.v.
12
Vericel corporation
8
Viatris inc.
120
Xencor, inc.
11
Symbols
AAPL
1198
ABB
1433
ABBV
1029
ABLZF
1172
ABT
1795
ACN
602
AMGN
744
ARVL
4301
AVGO
597
AZN
667
BDX
796
BMY
662
BNPQF
1765
BNPQY
1765
CSCO
899
DHR
785
ERIC
1614
F
643
FNCTF
7207
FRBA
600
GE
918
GLAXF
661
GOOG
1294
GOOGL
1293
GSK
887
HON
1791
HUBS
1400
IBM
655
INTC
955
IT
595
JNJ
4590
LLY
1710
LTUM
971
LYV
717
MDT
1285
MMM
938
MS
4289
MSFT
1202
MT
591
NOK
902
NOKBF
978
NVO
634
NVS
1243
NVSEF
1033
ORCL
1160
PCRFF
651
PCRFY
651
PFE
693
PHG
963
PPRUF
1129
PPRUY
1130
SAP
1480
SAPGF
1234
SNOW
796
SNY
4546
SNYNF
3604
TEVJF
632
TMO
1626
VZ
1218
XYF
678
Exchanges
Amex
7
Nasdaq
1158
Nyse
1243
Crawled Date
2024 - 01 - 17
5
2023 - 12 - 12
5
2023 - 12 - 08
6
2023 - 10 - 04
5
2023 - 10 - 03
4
2023 - 10 - 02
4
2023 - 09 - 29
4
2023 - 08 - 28
4
2023 - 08 - 25
7
2023 - 08 - 09
4
2023 - 06 - 12
5
2023 - 06 - 08
7
2023 - 04 - 28
4
2023 - 04 - 26
5
2023 - 04 - 25
4
2023 - 04 - 13
6
2023 - 04 - 12
12
2023 - 03 - 16
4
2023 - 02 - 27
4
2023 - 02 - 24
4
2023 - 02 - 22
4
2023 - 02 - 20
4
2023 - 02 - 17
7
2023 - 02 - 16
5
2023 - 02 - 14
4
2023 - 02 - 13
4
2023 - 01 - 18
4
2023 - 01 - 16
4
2022 - 12 - 15
4
2022 - 09 - 28
4
2022 - 09 - 19
6
2022 - 09 - 13
4
2022 - 09 - 02
4
2022 - 08 - 03
4
2022 - 07 - 25
4
2022 - 06 - 27
4
2022 - 06 - 24
4
2022 - 06 - 17
6
2022 - 05 - 27
5
2022 - 05 - 25
4
2022 - 05 - 05
4
2022 - 04 - 26
4
2022 - 03 - 25
6
2022 - 03 - 22
4
2022 - 03 - 17
4
2022 - 03 - 14
4
2022 - 03 - 08
4
2022 - 03 - 04
4
2021 - 12 - 22
5
2021 - 12 - 20
4
2021 - 10 - 28
4
2021 - 10 - 20
4
2021 - 09 - 01
4
2021 - 08 - 25
4
2021 - 08 - 19
5
2021 - 08 - 05
6
2021 - 06 - 02
4
2021 - 05 - 10
4
2021 - 04 - 13
4
2021 - 03 - 18
5
Crawled Time
00:00
45
00:20
10
01:00
47
01:08
1
02:00
25
03:00
34
04:00
23
04:20
8
05:00
24
06:00
69
06:03
2
07:00
39
08:00
34
08:20
4
08:23
1
09:00
45
10:00
33
11:00
52
11:01
1
12:00
83
12:15
6
12:20
16
12:30
9
13:00
35
13:14
1
13:15
7
13:20
8
13:30
5
13:35
1
13:58
1
14:00
50
14:15
2
14:20
10
14:30
7
14:49
1
15:00
55
15:15
4
15:20
16
15:30
16
16:00
56
16:01
1
16:20
4
17:00
65
18:00
55
19:00
45
20:00
48
20:20
3
21:00
34
22:00
56
22:01
1
23:00
44
23:09
1
Source
investors.biomarin.com
1
ir.voyagertherapeutics.com
2
spacfeed.com
1
www.biospace.com
126
www.globenewswire.com
227
www.perion.com
1
www.precisionbiosciences.com
3
www.prnewswire.com
881
www.voyagertherapeutics.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Nvs
save search
Novartis delivers double-digit sales growth and core margin expansion in Q1; FY 2024 guidance raised
Published:
2024-04-23
(Crawled : 05:00)
- globenewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
MOR
|
News
|
$17.97
-0.06%
-0.06%
330K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
Email alert
Add to watchlist
MPSYF
|
News
|
$70.28
-71.33%
110
|
Health Technology
|
Email alert
Add to watchlist
sales
expansion
novartis
growth
Over-The-Counter Drug Market size is set to grow by USD 58.54 billion from 2023-2027, Abbott Laboratories, Achelios Therapeutics Inc. and AstraZeneca Plc, and more to emerge as Some of the Key Vendors, Technavio
Published:
2024-04-22
(Crawled : 22:00)
- prnewswire.com
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$70.12
2.29%
2.24%
4.8M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$136.2
-4.19%
1.7K
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$107.07
-0.2%
0.0%
4.9M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$40.59
2.11%
-0.36%
3.8M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
Email alert
Add to watchlist
RBGPF
|
News
|
$51.75
6.46%
3.6K
|
Consumer Non-Durables
|
Email alert
Add to watchlist
RBGLY
|
News
|
$10.35
-2.05%
500K
|
Manufacturing
|
Email alert
Add to watchlist
drug
astrazeneca
set
key
therapeutics
market
Viral Vector and Plasmid DNA Technologies: A Global Market Perspective
Published:
2024-04-17
(Crawled : 10:00)
- prnewswire.com
TMO
|
News
|
$548.38
0.66%
0.29%
1.5M
|
Health Technology
|
-1.6%
|
O:
-0.26%
H:
0.03%
C:
-1.55%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
2.1%
|
O:
0.87%
H:
0.16%
C:
-0.59%
RGNX
|
$15.68
-0.06%
-0.06%
440K
|
Health Technology
|
-12.36%
|
O:
-1.43%
H:
2.27%
C:
-3.18%
global
dna
market
Novartis Kesimpta® six-year efficacy data show substantial benefits in recently diagnosed treatment- naïve people with relapsing multiple sclerosis
Published:
2024-04-17
(Crawled : 06:00)
- globenewswire.com
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
2.1%
|
O:
0.87%
H:
0.16%
C:
-0.59%
kesimpta
sclerosis
novartis
show
benefits
Emphysema Treatment Market to Reach $8.7 Billion, Globally, by 2032 at 3.3% CAGR: Allied Market Research
Published:
2024-04-16
(Crawled : 14:00)
- prnewswire.com
VTRS
|
News
A
|
$11.235
-0.13%
-0.13%
5.1M
|
Health Technology
|
-0.62%
|
O:
-0.53%
H:
0.0%
C:
-1.24%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
0.61%
|
O:
-1.46%
H:
0.0%
C:
0.0%
PHG
|
News
|
$20.61
3.15%
0.05%
1.6M
|
Health Technology
|
-0.29%
|
O:
-1.21%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.59
2.11%
-0.36%
3.8M
|
Health Technology
|
0.22%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
VRNA
|
$15.75
0.19%
0.19%
460K
|
Health Technology
|
-0.51%
|
O:
1.65%
H:
2.43%
C:
0.87%
reach
treatment
research
market
Ocular Therapeutix™ Strengthens Clinical Team with Appointment of Key Retinal Leaders
Published:
2024-04-16
(Crawled : 11:00)
- globenewswire.com
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
0.61%
|
O:
-1.46%
H:
0.0%
C:
0.0%
REGN
|
News
|
$899.71
0.32%
0.32%
340K
|
Health Technology
|
-1.62%
|
O:
-1.94%
H:
0.43%
C:
-0.34%
OCUL
|
News
|
$5.075
-2.78%
-2.86%
3.7M
|
Health Technology
|
-34.37%
|
O:
-1.03%
H:
3.66%
C:
1.7%
ocular
key
leaders
Biologic Therapeutics Market size is set to grow by USD 286.12 billion from 2023-2027, Introduction of biosimilars boost the market, Technavio
Published:
2024-04-15
(Crawled : 22:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-0.29%
|
O:
-1.75%
H:
0.85%
C:
0.85%
AZNCF
|
News
|
$136.2
-4.19%
1.7K
|
Health Technology
|
2.05%
|
O:
2.1%
H:
0.0%
C:
-2.52%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
0.61%
|
O:
-1.46%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.59
2.11%
-0.36%
3.8M
|
Health Technology
|
0.22%
|
O:
-1.19%
H:
0.52%
C:
-0.17%
BAX
|
$40.4
2.36%
0.0%
3.2M
|
Health Technology
|
0.9%
|
O:
-0.1%
H:
0.13%
C:
-1.08%
ABBV
|
News
|
$167.89
0.89%
0.0%
5.6M
|
Health Technology
|
3.85%
|
O:
0.32%
H:
0.96%
C:
0.22%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-1.27%
|
O:
-2.13%
H:
0.0%
C:
0.0%
BMRN
|
$89.52
1.0%
0.99%
1.2M
|
Health Technology
|
-2.21%
|
O:
-0.72%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.12
2.29%
2.24%
4.8M
|
Health Technology
|
2.04%
|
O:
-0.64%
H:
0.45%
C:
-0.04%
AMGN
|
News
|
$271.98
1.13%
1.12%
2.1M
|
Health Technology
|
2.41%
|
O:
0.41%
H:
0.0%
C:
0.0%
set
therapeutics
market
New Novartis Fabhalta® (iptacopan) data show clinically meaningful and statistically significant proteinuria reduction of 38.3% versus placebo for patients with IgA nephropathy (IgAN)
Published:
2024-04-15
(Crawled : 18:00)
- globenewswire.com
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
0.61%
|
O:
-1.46%
H:
0.0%
C:
0.0%
fabhalta
nephropathy
for
novartis
show
Arvinas Enters into a Transaction with Novartis, including a Global License Agreement for the Development and Commercialization of PROTAC® Androgen Receptor (AR) Protein Degrader ARV-766 for the Treatment of Prostate Cancer
Published:
2024-04-11
(Crawled : 11:00)
- globenewswire.com
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
0.22%
|
O:
0.32%
H:
0.04%
C:
-0.56%
ARVN
|
$34.91
0.55%
0.54%
850K
|
Health Technology
|
-3.4%
|
O:
8.28%
H:
0.56%
C:
-4.75%
arv-766
protac
license
cancer
treatment
global
protein
for
commercialization
agreement
Novartis tender offer for MorphoSys AG commences
Published:
2024-04-11
(Crawled : 09:00)
- globenewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
1.07%
|
O:
-0.32%
H:
0.48%
C:
-0.17%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
0.22%
|
O:
0.32%
H:
0.04%
C:
-0.56%
MOR
|
News
|
$17.97
-0.06%
-0.06%
330K
|
Health Technology
|
-0.14%
|
O:
0.69%
H:
0.0%
C:
-0.39%
for
novartis
Central Nervous System (CNS) Stimulant Drugs Market size is set to grow by USD 6.48 billion from 2023-2027, Rise in incidence of CNS disorders boost the market, Technavio
Published:
2024-04-10
(Crawled : 09:00)
- prnewswire.com
ALPMF
|
News
|
$9.75
43.47%
200
|
Health Technology
|
-9.51%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.65%
|
O:
-0.01%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-0.62%
|
O:
-1.67%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.5
-1.11%
1M
|
Manufacturing
|
-8.98%
|
O:
-0.29%
H:
0.0%
C:
-1.97%
VTRS
|
News
A
|
$11.235
-0.13%
-0.13%
5.1M
|
Health Technology
|
-4.01%
|
O:
-0.6%
H:
1.03%
C:
0.52%
TMO
|
News
|
$548.38
0.66%
0.29%
1.5M
|
Health Technology
|
-6.93%
|
O:
-2.01%
H:
0.0%
C:
0.0%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
-0.94%
|
O:
-1.16%
H:
0.0%
C:
0.0%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-2.64%
|
O:
-0.32%
H:
0.0%
C:
0.0%
JAZZ
|
$108.81
-1.03%
-1.04%
510K
|
Health Technology
|
-5.88%
|
O:
-1.71%
H:
0.57%
C:
0.37%
disorders
system
set
market
Eczema Therapeutics Market size is set to grow by USD 5.81 bn from 2024-2028,high prevalence of atopic dermatitis boost the market- Technavio
Published:
2024-04-08
(Crawled : 18:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.01%
|
O:
2.24%
H:
0.0%
C:
-0.8%
AZNCF
|
News
|
$136.2
-4.19%
1.7K
|
Health Technology
|
4.14%
|
O:
-3.43%
H:
6.21%
C:
6.21%
VTRS
|
News
A
|
$11.235
-0.13%
-0.13%
5.1M
|
Health Technology
|
-4.66%
|
O:
-0.25%
H:
1.1%
C:
-0.17%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
-1.06%
|
O:
-0.05%
H:
0.43%
C:
-0.27%
BMY
|
$49.14
0.43%
0.0%
7.9M
|
Health Technology
|
-4.25%
|
O:
-0.08%
H:
0.04%
C:
-0.35%
BHC
|
$8.45
-2.76%
0.24%
2.3M
|
Health Technology
|
-18.83%
|
O:
0.38%
H:
0.0%
C:
-7.27%
ABBV
|
News
|
$167.89
0.89%
0.0%
5.6M
|
Health Technology
|
-0.02%
|
O:
0.77%
H:
1.63%
C:
0.35%
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
-1.39%
|
O:
0.84%
H:
0.0%
C:
0.0%
AZN
|
News
|
$70.12
2.29%
2.24%
4.8M
|
Health Technology
|
3.97%
|
O:
0.18%
H:
0.3%
C:
0.19%
eczema
dermatitis
set
therapeutics
market
New Novartis data show early addition of twice-yearly* Leqvio® (inclisiran) following maximally tolerated statin therapy significantly reduces LDL-C in ASCVD patients in real-world setting
Published:
2024-04-06
(Crawled : 20:20)
- globenewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
Email alert
Add to watchlist
leqvio
novartis
therapy
show
Positron Emission Tomography Market size is set to grow by USD 725.97 mn from 2024-2028,increasing prevalence of chronic conditions worldwide boost the market- Technavio
Published:
2024-04-03
(Crawled : 06:00)
- prnewswire.com
CAJPY
|
$28.23
-0.41%
22K
|
n/a
|
-2.64%
|
O:
-0.3%
H:
0.54%
C:
0.54%
CAJFF
|
$29.0664
-28.15%
760
|
Electronic Technology
|
-2.61%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
0.12%
|
O:
-2.86%
H:
0.17%
C:
0.17%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
0.38%
|
O:
0.04%
H:
0.46%
C:
-0.08%
PHG
|
News
|
$20.61
3.15%
0.05%
1.6M
|
Health Technology
|
3.46%
|
O:
1.0%
H:
0.0%
C:
0.0%
worldwide
set
market
NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer
Published:
2024-04-01
(Crawled : 12:00)
- globenewswire.com
NAMS
|
$20.42
2.46%
2.4%
85K
|
n/a
|
-9.71%
|
O:
6.23%
H:
2.77%
C:
-10.21%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
-1.67%
|
O:
0.47%
H:
0.23%
C:
-0.99%
pharma
business
Carisma Therapeutics Announces Changes to its Board of Directors
Published:
2024-04-01
(Crawled : 11:00)
- prnewswire.com
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
-1.67%
|
O:
0.47%
H:
0.23%
C:
-0.99%
CRIS
|
$14.6
2.03%
1.99%
21K
|
Health Technology
|
37.82%
|
O:
0.7%
H:
16.87%
C:
16.87%
therapeutics
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published:
2024-03-29
(Crawled : 18:00)
- prnewswire.com
BMY
|
$49.14
0.43%
0.0%
7.9M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$66.95
0.29%
0.28%
5.6M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$271.98
1.13%
1.12%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
GMAB
|
News
|
$28.97
0.94%
0.93%
450K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$47.125
1.78%
1.75%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
Email alert
Add to watchlist
GNMSF
|
News
|
$284.55
3.83%
240
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$167.89
0.89%
0.0%
5.6M
|
Health Technology
|
Email alert
Add to watchlist
research
global
leukemia
therapeutics
market
LASIK Surgery Market size to record USD 1.24 bn growth from 2024-2028, Increasing medical tourism for LASIK surgery is one of the key market trends, Technavio
Published:
2024-03-28
(Crawled : 22:00)
- prnewswire.com
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$107.07
-0.2%
0.0%
4.9M
|
Health Technology
|
Email alert
Add to watchlist
ALC
|
$80.61
1.33%
0.0%
520K
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
one
key
medical
growth
market
CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
Published:
2024-03-28
(Crawled : 19:00)
- globenewswire.com
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
Email alert
Add to watchlist
AVEO
|
$15.0
0.0%
0
|
Health Technology
|
Email alert
Add to watchlist
AUTL
|
$4.58
1.33%
1.31%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
medical
Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases
Published:
2024-03-28
(Crawled : 15:30)
- prnewswire.com
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
-4.25%
|
O:
0.99%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$93.6375
6.88%
82K
|
Health Technology
|
-0.6%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
News
|
$95.12
0.81%
-1.18%
2.4M
|
Health Technology
|
-1.16%
|
O:
0.52%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$149.12
0.82%
0.0%
9.3M
|
Health Technology
|
-4.47%
|
O:
1.32%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.59
2.11%
-0.36%
3.8M
|
Health Technology
|
-5.58%
|
O:
0.02%
H:
0.51%
C:
-0.3%
LLY
|
News
|
$731.33
0.69%
0.0%
2.3M
|
Health Technology
|
-6.02%
|
O:
0.28%
H:
1.71%
C:
-0.3%
BMY
|
$49.14
0.43%
0.0%
7.9M
|
Health Technology
|
-7.72%
|
O:
0.26%
H:
2.03%
C:
1.57%
AMGN
|
News
|
$271.98
1.13%
1.12%
2.1M
|
Health Technology
|
-5.03%
|
O:
0.54%
H:
0.0%
C:
0.0%
antibody
research
global
← Previous
1
2
3
4
5
6
7
8
9
…
62
63
Next →
Gainers vs Losers
75%
25%
Top 10 Gainers
MTTR
|
News
M
|
$4.78
174.71%
63.6%
72M
|
AGBA
|
$2.565
105.2%
51.27%
200M
|
Finance
MLEC
|
$2.44
74.29%
42.62%
78M
|
n/a
EDBL
|
News
|
$6.28
67.02%
40.13%
16M
|
ATGL
|
$2.91
48.81%
32.8%
180K
|
ZAPP
|
$0.2175
47.16%
32.05%
16M
|
n/a
ONFO
|
$0.6075
38.38%
27.74%
7.3M
|
n/a
VIVK
|
$1.48
38.32%
27.7%
530K
|
Professional, Scientific, and T...
MNTS
|
$0.5
35.69%
26.3%
4.8M
|
SDIG
A
|
$3.635
35.13%
26.0%
1M
|
Your saved searches
Save your searches and get alerts when important news are released.